Intent to Sole Source Preventative Maintenance Tender - 140412599

Procurement Summary

Country: USA

Summary: Intent to Sole Source Preventative Maintenance Agreement for 4 Apheresis Machines Optias

Deadline: 13 May 2026

Posting Date: 30 Apr 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 140412599

Document Ref. No.: NOI-OLAO-CC-26-005158

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Terumo BCT.
Acquisition Descripton:
The National Institutes of Health, Office of Purchasing and Contracts on behalf of Clinical Center (CC), Blood Services Section (BSS) has a need to approve a "Justification for Other Than Full and Open" requirement in accordance with FAR 8.3, Other Than Full and Open Competition.
This procurement action in accordance with IAW FAR 6.302-1 is based on the need to procure a service agreement for our apheresis machines which are used in a patient care capacity. Service Agreement is for a one-year period with the two option years.
Approval of this purchase is for service agreement for a specific type of instrument which is used to separate blood and blood products on donors and patients in the NIH Clinical Center.
The DTM is a unique blood center which collects blood and blood components from healthy donors for patients participating in many protocols. However, blood and blood products are also withdrawn from patients when prescribed by a physician, which may have a therapeutic benefit to treat their medical condition. These two (2) apheresis machines are used to perform extracorporeal therapy in which the blood of donors or patients is passed through the device to separate blood components. Numerous regulatory authorities, specifically the Food and Drug Administration (FDA) and AABB set policy and enforce this policy for care and maintenance of equipment that is used, in support of donors and patients per the above.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required ma...
Notice ID: noi-olao-cc-26-005158

Department/Ind. Agency: health and human services, department of

Sub-tier: national institutes of health

Product Service Code: j049 - maint/repair/rebuild of equipment- maintenance and repair shop equipment

NAICS Code: 339112 - Surgical and Medical Instrument Manufacturing

Inactive Dates: may 28, 2026

Inactive Policy: 15 days after response date

Documents

 Tender Notice